Patent Yard Sign in
Expired Australian patentAustralia

Method of treating renal disease by administering IGF-I and IGFBP-3

AU 1995010982 · Applicant: Celtrix Pharmaceuticals Inc

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 15, 1994 and granted August 20, 1998. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by November 15, 2015.
  • A pharmaceutical extension adds at most five years, so even that would have ended by November 15, 2020.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 15, 1994
GrantedAugust 20, 1998
Term ended byNovember 15, 2015
Application numberAU 1995010982
Classification (IPC)A61P3/08 +2 more

Timeline

Timeline From IP Australia dates

1995199820012004200720102013Application filedNov 15, 1994Patent grantedAug 20, 1998Term ended byNov 15, 2015

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.